What
Where
AWARD IDIQ FOR THE CONTRACEPTIVE CLINICAL TRIALS NETWORK FEMALE SITES TO PERFORM PHASE I, II, III, AND PHASE IV CLINICAL TRIALS OF A WIDE VARIETY OF NEW OR EXIS...
From: Federal Procurement Data System(Federal)
 Basic Details |  Start Date08 Aug, 2020 (about 3 years ago) Due Date31 Jul, 2027 (in about 3 years) TypeContractIdentifierRFP-NIH-NICHD-CDP-2020-1 | ||||
 Customer / Agency | NATIONAL INSTITUTES OF HEALTH | ||||
Unlock the best of InstantMarkets.Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.
Don't have an account yet? Create a free account now.
AWARD IDIQ FOR THE CONTRACEPTIVE CLINICAL TRIALS NETWORK FEMALE SITES TO PERFORM PHASE I, II, III, AND PHASE IV CLINICAL TRIALS OF A WIDE VARIETY OF NEW OR EXISTING FEMALE CONTRACEPTIVE METHODS.
Solicitation ID/Procurement Identifier: RFP-NIH-NICHD-CDP-2020-1
Ultimate Completion Date: Sat Jul 31 17:00:00 GMT
Solicitation ID/Procurement Identifier: RFP-NIH-NICHD-CDP-2020-1
Ultimate Completion Date: Sat Jul 31 17:00:00 GMT
Location
Address: USA,
Country : United StatesYou may also like
NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed)
Due: 16 Mar, 2025 (in 10 months)Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Due: 07 Jan, 2027 (in about 2 years)Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Due: 19 Aug, 2026 (in about 2 years)Please Sign In to see more like these.
Don't have an account yet? Create a free account now.